Enestia Belgium NV
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- Belgium
- Registered address
- Klocknerstraat 1, Hamont-Achel, B-3930, Belgium (BEL)
- Operations here
- labelpack
- FDA identifiers
- FEI 3002958688 · DUNS 282797240
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2024-12-13
- NAIDrug Quality Assurance2017-12-15
- VAIDrug Quality Assurance2016-03-11
Drugs this plant is listed as making
1 distinct drugs across 1 products name this site in their FDA label.
- caplacizumabGenzyme Corporation
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.